About: ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2004 (fr) наукова стаття, опублікована в листопаді 2004 (uk) scientific article published on 01 November 2004 (en) artículu científicu espublizáu en payares de 2004 (ast)
publication date	wds:Q81073192-581B3177-890C-484E-81B0-4338AF94CE19
publication date	2004-11-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q81073192-0ADB2348-285E-49ED-A51E-73EA297D75E3 wds:Q81073192-0CA851BA-9098-4055-B6DD-13E073721BC0 wds:Q81073192-24F70BE0-FF29-4218-8548-32D8EB112E82 wds:Q81073192-254701AB-6CA8-4F8A-A942-E8143CF513E7 wds:Q81073192-4F778FBC-979A-47BB-8454-1139BDC27A8F wds:Q81073192-59712220-64FD-4107-B827-E7826270A582 wds:Q81073192-68C7976C-D7D4-4DD7-80EC-483ADBD29444 wds:Q81073192-87EDAB1D-C146-4E9E-B8C4-AE58A718751C wds:Q81073192-8D0CD5C6-6C04-48AF-A38E-14EC83961A8D wds:Q81073192-9C55F0FA-96AE-4C13-8E44-78BE89110BE1 wds:Q81073192-F6E97357-4581-466D-B276-F08934713B8B wds:Q81073192-F9A14A71-993E-4855-977A-45E653EB6B17
author name string	Johann S de Bono Robert J Bauer Amita Patnaik Anthony W Tolcher Eric K Rowinsky Lisa A Hammond Chris Takimoto Albert F LoBuglio Mark L White Andre Forero Gertrude F A Vanhove Muhammad B Khazaeli
rdfs:label	ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas (en) ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas (nl)
skos:prefLabel	ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas (en) ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas (nl)
name	ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas (en) ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas (nl)
author	wds:Q81073192-23A0526B-43EC-4134-BCAF-BF52D70EAA41
author	Sui Shen
title	wds:Q81073192-993AD4A5-0AAE-45A0-91C1-BAA8A961810B
title	ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas (en)
page(s)	wds:Q81073192-8CF2A939-652F-483E-AC29-B0011EC71978
page(s)	7555-7565
instance of	wds:Q81073192-0EE50DDD-25E4-445B-8FBD-03D0F476FDAB
instance of	scholarly article
main subject	wds:Q81073192-3E316C6A-0B5C-4915-8F75-C48F07F1A4C6 wds:Q81073192-DC514B28-F3CB-4ED7-9077-766FC5264D8B
main subject	monoclonal antibody adenocarcinoma
PubMed ID	wds:Q81073192-DBF72375-889D-41B7-8767-070F23102218
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15569986
PubMed ID	15569986
published in	wds:Q81073192-36DD902D-8675-4B29-BDF8-D2B301ABBE7C
published in	Clinical Cancer Research
issue	wds:Q81073192-DB97B252-54BA-47C9-8E87-C574C4DFCCC9
volume	wds:Q81073192-0E97B369-3028-4401-8140-DB99BCFABBDE
issue	22
volume	10
DOI	wds:Q81073192-93F940E4-B778-458B-9BB8-A9152BA2E222
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-04-0729
DOI	10.1158/1078-0432.CCR-04-0729
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81073192
is cites work of	Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors Population pharmacokinetics of therapeutic monoclonal antibodies Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer 68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors. Efficient Epidermal Growth Factor Receptor Targeting Oligonucleotide as a Potential Molecule for Targeted Cancer Therapy Construction, expression, and characterization of a recombinant immunotoxin targeting EpCAM. Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain A preliminary study on treatment of human breast cancer xenografts with a cocktail of paclitaxel, doxorubicin, and I-anti-epithelial cell adhesion molecule (9C4) Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection. Expression of tumor-associated calcium signal transducer 2 in patients with salivary adenoid cystic carcinoma: Correlation with clinicopathological features and prognosis
is cites work of	wds:Q36677197-45DC62A5-14DF-4535-8D68-9E60EBB4140E wds:Q41592942-AE3EEA18-9A28-4B82-817F-ED9D327D6C7C wds:Q90225292-CFA3F26D-F51C-4DD2-A03F-EFC4398194B4 wds:Q35556641-2BC602D7-08C0-4FE1-A425-0142BBE8EA7E wds:Q36706795-E1061AF1-CC20-41C9-B31F-EF9B09095B0B wds:Q37785528-68A6352E-AEE2-4263-A112-59599F35FC7E wds:Q64903009-CA8B5677-0492-4B3A-8AF9-FB92784C33A3 wds:Q61810786-D3B78211-E437-4FFD-A586-416CA038B69C wds:Q50041876-1C22CCEB-67D1-4266-9A75-F49A485AC05B wds:Q30427356-40665B36-3E9D-406E-9757-6B8EEEA60A88 wds:Q36413078-066D3E09-9E93-480E-BEB5-C47404A67BFB wds:Q36944033-3C569F4E-7117-40E6-80F9-FC44BC7C17B2 wds:Q28235980-EDB66955-C6AD-413A-B4B3-F0ED3831E4C7 wds:Q36404430-71DD357A-26F6-41ED-A2AA-785B04A286E4 wds:Q41870632-1CB06451-DEEA-42CE-B8A5-E0407B4390D5 wds:Q58217966-5CD40A91-F689-40E6-BD12-11639A322351

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software